ENTRY       D02997                      Drug
NAME        Asparaginase (USAN);
            L-Asparaginase (JAN);
            Asparaginase Erwinia chrysanthemi (USAN);
            Asparaginase erwinia chrysanthemi (recombinant)-rywn;
            Elspar (TN);
            Erwinaze (TN);
            Rylaze (TN)
PRODUCT     RYLAZE (Jazz Pharmaceuticals)
SOURCE      Escherichia coli [TAX:562] (JAN), Erwinia chrysanthemi [TAX:556] (USAN)
REMARK      Therapeutic category: 4291
            ATC code: L01XX02
            Product: D02997<JP/US>
EFFICACY    Antineoplastic, Enzyme (L-asparaginase)
  DISEASE   Acute lymphoblastic leukemia [DS:H00001 H00002]
COMMENT     PEG-L-asparaginase
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX02 Asparaginase
                  D02997  Asparaginase (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antineoplastics, Other
               Asparaginase Erwinia
                D02997  Asparaginase (USAN)
               Asparaginase Erwinia (Recombinant)
                D02997  Asparaginase (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D02997  Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02997
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02997
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02997
DBLINKS     CAS: 9015-68-3
            PubChem: 17397153
///
